Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Instituto do Cancer do Estado de São Paulo
University Hospital Tuebingen
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Travera Inc
West China Hospital
West China Hospital
National Institutes of Health Clinical Center (CC)
Fudan University